Pushing the Limits of Medical Management in HCM: A Review of Current Pharmacological Therapy Options

Hypertrophic cardiomyopathy (HCM) is the most common monogenic cardiac disease with a highly variable phenotypic expression, ranging from asymptomatic to drug refractory heart failure (HF) presentation. Pharmacological therapy is the first line of treatment, but options are currently limited to nons...

Descripción completa

Detalles Bibliográficos
Autores principales: Stătescu, Cristian, Enachi, Ștefana, Ureche, Carina, Țăpoi, Laura, Anghel, Larisa, Șalaru, Delia, Pleșoianu, Carmen, Bostan, Mădălina, Marcu, Dragoș, Ovanez Balasanian, Mircea, Sascău, Radu Andy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268685/
https://www.ncbi.nlm.nih.gov/pubmed/34281272
http://dx.doi.org/10.3390/ijms22137218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8268685/
https://www.ncbi.nlm.nih.gov/pubmed/34281272
http://dx.doi.org/10.3390/ijms22137218

Ejemplares similares